Author

W. Fantl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Delgado-Gonzalez· 1 shared A. Gentles· 1 shared E. Porpiglia· 1 shared K. Donoso· 1 shared K. Sachs· 1 shared S.-Y. Chen· 1 shared V. D. Gonzalez· 1 shared Y.-W. Huang· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Delgado-Gonzalez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

High-Grade Serous Ovarian Tumor Cells Modulate NK Cell Function to Create an Immune-Tolerant Microenvironment

V. D. Gonzalez, Y.-W. Huang, S.-Y. Chen, A. Delgado-Gonzalez, K. Donoso, A. Gentles, K. Sachs, E. Porpiglia, W. Fantl

This study identifies CD9 as a novel therapeutic target in high-grade serous ovarian cancer by showing tumor cells modulate NK cell function through trogocytosis.

bioRxiv · Nov 20, 2020Immunology